Fate of Coronary Chronic Total Occlusion Recanalization via Subintimal Tracking With Bioresorbable Vascular Scaffolds: A Temporary Cage for a Permanent New Lumen?  by La Manna, Alessio et al.
FIGURE 1 Baseline
Representative pictu
follow-up (D) of bio
Baseline (A and B): t
artery after the prog
arrow shows a side b
true lumen of the di
raphy (OCT) image (B
and the OCT cathete
implantation (C): in
subintimal space, wh
image of 1-year follo
covered in the subin
Letters to the Editor J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 9 , 2 0 1 5
S E P T E M B E R 2 0 1 5 : 1 1 1 1 – 6
1114RE F E RENCE S
1. Filsouﬁ F, Carpentier A. Principles of reconstructive surgery in degenerative
mitral valve disease. Semin Thorac Cardiovasc Surg 2007;19:103–10.
2. Adams DH, Rosenhek R, Falk V. Degenerative mitral valve regurgitation:
best practice revolution. Eur Heart J 2010;31:1958–66.
3. Martin RP. How do we use imaging to aid considerations for intervention in
patients with severe mitral regurgitation? Ann Cardiothorac Surg 2013;2:779–86.
4. Rim Y, Laing ST, Kee P, McPherson DD, Kim H. Evaluation of mitral valve
dynamics. J Am Coll Cardiol Img 2013;6:263–8.
5. Rim Y, McPherson DD, Chandran KB, Kim H. The effect of patient-speciﬁc
annular motion on dynamic simulation of mitral valve function. J Biomech
2013;46:1104–12.Fate of Coronary Chronic Total Occlusion
Recanalization via Subintimal Tracking
With Bioresorbable Vascular Scaffolds:
A Temporary Cage for a Permanent New Lumen?A 62-year-old man was admitted as a result of stable
angina Canadian Cardiovascular Society class III., Post-Scaffolding, and 1-Year Follow-Up of BVS Implantation
res of baseline (A and B), post-scaffold implantation (C), and 1-year
resorbable vascular scaffold (BVS) implantation are demonstrated.
he angiographic image (A) illustrates the injection of the left coronary
ression of the guidewire in the false lumen (yellow arrow). The white
ranch. The blue arrows highlight the position of the guidewire in the
stal marginal branch. The cross-sectional optical coherence tomog-
) illustrates the subintimal space (red asterisk), where the guidewire
r are located, and the true lumen (white asterisk). Post-scaffold
this OCT image, the BVS appears well expanded and apposed in the
ereas hematoma is observed in the true lumen. Follow-up (D): OCT
w-up is demonstrated. The scaffold is well expanded, apposed, and
timal space.Coronary angiography showed a chronic total occlu-
sion (CTO) of the mid-left circumﬂex coronary artery
(LCX), which was ﬁlled by grade III collateral ﬂow from
the right coronary artery (RCA), whereas the left
anterior descending artery and RCA showed no
signiﬁcant stenoses (SYNTAX score ¼ 9.5). Cardiac
magnetic resonance demonstrated the presence of
stress-induced ischemia in the posterolateral wall.
Therefore, a CTO–percutaneous coronary intervention
(PCI) was undertaken. An attempt to cross the lesion
antegradely with an Ultimate Bros 3 guidewire (Asahi
Intecc, Aichi, Japan) was performed, leading to vessel
dissection and advancement of the guidewire in the
false lumen and re-entering the true lumen more
distally (Figure 1A). Optical coherence tomography
(OCT) (Ilumien, St. Jude Medical, St. Paul, Minnesota)
after pre-dilation revealed the entry point into the
subintimal space and re-entering in the true lumen
(Figure 1B). Excellent angiographic and OCT results
were obtained with the implantation of 2 (3.0  18 mm
and 3.5  28 mm) overlapping bioresorbable vascular
scaffolds (BVS) (Absorb, Abbot Vascular, Santa Clara,
California). Notably, subintimal scaffolding leading to
true lumen collapse in a short segment (9.7 mm) was
well demonstrated by OCT (Figure 1C). Follow-
up angiography and OCT were performed 1 year after
the index procedure, showing optimal results
(Figure 1D). The scaffold was well apposed in the sub-
intimal space, whereas the magnitude of neointimal
hyperplasia was comparable between the scaffold
located at the subintimal and intimal space.
In the present case, OCT clearly elucidated the
mechanism of subintimal wire tracking and scaf-
folding. A previous study has shown the possible
negative impact of subintimal metallic drug-eluting
stent implantation, including late stent malapposition
and fracture (1). The current case did not demonstrate
late scaffold malapposition or exacerbated neo-
intimal hyperplasia in the subintimal space. Although
the scaffold enlargement demonstrated in our case
was mostly due to hematoma absorption (i.e., heal-
ing), scaffold enlargement has recently been de-
monstrated late after BVS implantation (2). This
particular feature of BVS could reduce concerns
regarding late malapposition in complex scenarios,
such as CTO-PCI (3). Because long-term follow-up is
not available, we believe that BVS implantation in
the subintimal space should be considered only in
cases with short subintimal wiring without large
side branch compromise, whereas in cases with long
subintimal wiring with important side branch loss
(i.e., subintimal tracking and re-entry technique), it
would not be recommended because of the possible
risk of reocclusion (4).
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1115To our knowledge, this is the ﬁrst report of follow-
up OCT assessments in CTO lesions with BVS in-
cluding subintimal scaffolding. Although the results
herewith demonstrated are promising, we acknowl-
edge that longer-term follow-up imaging evalua-
tions would be able to provide further insights into the
assessment of scaffold reabsorption, whereas physi-
ological assessments would be able to test whether
vasodilation capabilities are recovered in this setting.
Further validation of our ﬁndings is warranted.Alessio La Manna, MD*
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the Assessment of Aortic Stenosis Valve AreaWe read with great interest the paper of Clavel et al.
(1) in this issue of iJACC. The authors focused on theelliptic shape of the left ventricular outﬂow tract
(LVOT) that was ﬁrst shown by Baumgartner on
transthoracic echocardiography in 1990 (2).
Clavel et al. compared the functional area
obtained by the substitution of the echocardio-
graphically calculated LVOT area by LVOT planim-
etry on 64-slice computed tomography (CT) in the
continuity equation (aortic valve area [AVA] CT)
with CT planimetry of the stenotic aortic valve (AVA
plani).
Two important messages are provided in their pa-
per: the threshold found for predicting mortality in
patients with medically treated aortic stenosis; and
the demonstration that some discrepancies between
the mean aortic valve gradient and the functional
AVA (AVA echo) is not the result of inadequacy in
measuring the LVOT area.
However, CT LVOT planimetry should be per-
formed exclusively in systole because, as shown for
the aortic annulus (3), the ellipticity index is less in
systole compared with that in diastole.
The good correlation of the AVA reached by the
continuity equation using the LVOT area calculated
by echocardiographic Doppler (AVA echo) with AVA
CT is not surprising because the 2 areas share the
same ratio (velocity time integral [VTI] outﬂow tract/
VTI aortic valve). This is also true for the mean aortic
valve gradient and AVA CT or AVA echo because this
gradient is related to 1/AVA2 (CT or echo).
The functional AVA (calculated by the continuity
equation) is a mean area in systole compared with the
anatomic aortic valve area, which is a maximal
instantaneous valve area in systole. When the valve is
calciﬁed and rigid, as in aortic stenosis, the aperture
is delayed and limited, increasing the difference be-
tween the anatomic area and the functional area. The
ﬂow convergence downstream from the anatomic
valve area also explains the lower value of the func-
tional area.
Although this study adds to the reliability of
echocardiographic Doppler assessment, CT planim-
etry of aortic stenosis remains an alternative in cases
of poor acoustic window or when the continuity
equation is inaccurate (high dynamic gradient of the
LVOT). CT adds the incremental prognostic value of
valve calcium scoring (4). There is a 0.2 cm2 upward
shift of the threshold to deﬁne signiﬁcant stenosis on
AVA CT planimetry compared with the AVA echo
functional area (5).Michel Habis, MD*
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